Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Navarre Institute of Health Research

InstitutionResearch output, impact & collaborations

Navarre Institute of Health Research is a research organisation in Pamplona, ES. OpenAlex records 6,933 works and 597,818 citations for it. 1,727 researchers list it as their most recent affiliation.

6,933
Works
597,818
Citations
1,727
Researchers
82
Avg h-index

How has Navarre Institute of Health Research's publication output changed over time?

ScholarIQpublication output · 1999–2023

Output grew200% over the shown period — from 1 works in 1999 to 3 in 2023.

1
1
2
2
3
3
199920092019202120222023

Who are the most-cited researchers behind Navarre Institute of Health Research?

ScholarIQtop researchers by citations
1
Paula Rodríguez‐Otero · Multiple Myeloma Research and Treatments
684 works13,122 citations

What are the most-cited papers on Navarre Institute of Health Research?

ScholarIQmost cited works
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
New England Journal of Medicine. 20212,479 CitationsOPEN ACCESS
Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
JJM van Dongen, EA Macintyre, J Gäbert, Éric Delabesse, V Rossi, Giuseppe Saglio, Enrico Gottardi, Alessandro Rambaldi, Gianpietro Dotti, Frank Griesinger, A Parreira, Paula Gameiro, M González Diáz, M Malec, A W Langerak, Jesús F. San Miguel, Andrea Biondi
S149476849. 19991,166 Citations
Teclistamab in Relapsed or Refractory Multiple Myeloma
Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San Miguel, Albert Oriol, Ajay K. Nooka, Thomas G. Martin, Laura Rosiñol, Ajai Chari, Lionel Karlin, Lotfi Benboubker, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Surbhi Sidana, Michel Delforge, Lixia Pei, Danielle Trancucci, Raluca Verona, Suzette Girgis, Shun Xin Wang Lin, Yunsi Olyslager, Mindy Jaffe, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Jenna D. Goldberg, Rachel Kobos, Amrita Krishnan, Saad Z. Usmani
New England Journal of Medicine. 20221,160 CitationsOPEN ACCESS
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Sagar Lonial, Hans C. Lee, Ashraf Badros, Suzanne Trudel, Ajay K. Nooka, Ajai Chari, Al‐Ola Abdallah, Natalie S. Callander, Nikoletta Lendvai, Douglas W. Sborov, Attaya Suvannasankha, Katja Weisel, Lionel Karlin, Edward N. Libby, Bertrand Arnulf, Thierry Façon, Cyrille Hulin, K. Martin Kortüm, Paula Rodríguez‐Otero, Saad Z. Usmani, Parameswaran Hari, Rachid Baz, Hang Quach, Philippe Moreau, Peter M. Voorhees, Ira Gupta, Axel Hoos, Eric Zhi, January Baron, Trisha Piontek, Eric Lewis, Roxanne C. Jewell, Elisha J. Dettman, Rakesh Popat, Simona Degli Esposti, Joanna Opalinska, Paul G. Richardson, Adam D. Cohen
The Lancet Oncology. 2019806 Citations
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel, Michèle Cavo, Ajay K. Nooka, Salomon Manier, Natalie S. Callander, Luciano J. Costa, Ravi Vij, Nizar J. Bahlis, Philippe Moreau, Scott R. Solomon, Michel Delforge, Jesús G. Berdeja, Anna Truppel-Hartmann, Zhihong Yang, Linda Favre‐Kontula, Fan Wu, Julia Piasecki, Mark Cook, Sergio Giralt
New England Journal of Medicine. 2023733 CitationsOPEN ACCESS

How much of the research on Navarre Institute of Health Research is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
25%
Bronze
25%
Closed
33%

Related on ScholarIQ

Nutritional Studies and Diet
Top Topic
Diet and metabolism studies
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Obesity, Physical Activity, Diet
Top Topic
Multiple Myeloma Research and Treatments
Top Topic
CAR-T cell therapy research
Top Topic
470M+ articles · free account